NCT06858501 2025-12-31
Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma
Children's Oncology Group
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT06852807 2025-08-08
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
First Affiliated Hospital of Zhejiang University
Recruiting
NCT06813742 2025-08-07
18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
First Affiliated Hospital of Zhejiang University
Recruiting
NCT04724369 2025-03-26
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Phase 3 Completed
NCT06233903 2025-01-21
18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Phase 2 Withdrawn
NCT05069220 2024-03-01
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Recruiting